-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
The company has been honored with multiple accolades, including “Top 100 Chinese Pharmaceutical Companies.”
Category:
发布时间：2019-07-15
【概要描述】
Recently, the “2018 China Pharmaceutical Industry Most Influential Rankings Release Ceremony and the 11th China (Jinan) Pharmaceutical Industry Development Summit Forum,” supported by the All-China Federation of Industry and Commerce, organized by the Pharmaceutical Industry Chamber of the All-China Federation of Industry and Commerce, co-organized by the Jinan Municipal Federation of Industry and Commerce, the Jinan Municipal Health Commission, and assisted by the Shandong Provincial Pharmaceutical Chamber of Commerce, was successfully held in Jinan, Shandong Province, drawing extensive attention from the pharmaceutical industry and broader society. The China Pharmaceutical Industry Most Influential Rankings Release Ceremony has been held consecutively for five sessions, serving as the annual flagship event for branding in China’s pharmaceutical sector. The selection process invites leading domestic experts and scholars to form the judging panel, adhering to the principle of “openness”
Recently, the “2018 China Pharmaceutical Industry Most Influential Rankings Release Ceremony and the 11th China (Jinan) Pharmaceutical Industry Development Summit Forum,” supported by the All-China Federation of Industry and Commerce, organized by the Pharmaceutical Industry Chamber of the All-China Federation of Industry and Commerce, co-organized by the Jinan Municipal Federation of Industry and Commerce, the Jinan Municipal Health Commission, and other entities, and assisted by the Shandong Provincial Pharmaceutical Chamber of Commerce, was successfully held in Jinan, Shandong Province, drawing extensive attention from the pharmaceutical industry and broader society.
The China Pharmaceutical Industry’s Most Influential Rankings Gala has been held for five consecutive years, serving as the annual flagship brand event of China’s pharmaceutical sector. The award selection process invites leading domestic experts and scholars to form a judging panel, adhering to the principles of “open solicitation, objective data, rigorous screening, and impartial evaluation.” As a result, the “2018 China Pharmaceutical Industry’s Most Influential Rankings” were finalized, recognizing industry-leading enterprises across all segments of the pharmaceutical value chain. Thanks to its high-quality development over recent years, the company has consecutively earned two prestigious honors: “Top 100 Chinese Pharmaceutical Manufacturers” and “Top 50 Growing Companies in the Chinese Pharmaceutical Industry.”
Behind these honors lies the unwavering commitment of the employees of Sihua Pharmaceutical to uphold the original aspiration of green pharmaceutical manufacturing and to remain steadfast in their dedication to Healthy China. As a large, integrated domestic pharmaceutical enterprise, the company has consistently adhered to its corporate mission of putting quality and public health first, while emphasizing R&D and meticulous management. Leveraging its technological strengths, it is committed to the development and production of high-quality, safe medicines that meet the needs of the public. Over more than seven decades of relentless effort, the company has earned widespread recognition from the national government, the industry, and various sectors of society. In 2018, the company achieved a 33% year-on-year increase in sales revenue and a 34.2% year-on-year rise in net profit, maintaining robust growth momentum and effectively playing a leading role in driving industry advancement, thereby making a positive contribution to local economic development.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091